Showing 31-40 of 1741 results for "".
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31295/Management of Acute Seizures and Long-Term Antiepileptic Therapy: A Case StudyIn a recent article by Niranjan Siva, MD, and Amit Verma, MD, published in *Practical Neurology*, a 24-year-old male experienced two first-time generalized tonic-clonic seizures without aura within a two-hour period. Initi
RENEU (A Study to Evaluate the Safety, Effectiveness, and Tolerability of Gomekli in Children Aged ≥2 Years and Adults with an Inoperable NF1-PN; NCT03962543)
https://practicalneurology.com/programs/practical-neurology/trials-in-2/35433/Christopher Moertel, MD, Medical Director of the Pediatric Neuro-Oncology and Neurofibromatosis Programs at the University of Minnesota provides an overview of the ReNeu clinical trial which evaluated the safety, effectiveness, and tolerability of Gomekli in children aged ≥2 years and adults.The Role of Advanced Genomic Testing in the Diagnosis and Treatment of Neurologic Conditions
https://practicalneurology.com/programs/practical-neurology/the-role-of-advanced-genomic-testing-in-the-diagnosis-and-treatment-of-neurologic-conditions/30100/Paul Kruszka, MD, Chief Medical Officer at GeneDx, discusses advanced genomic testing, emphasizing how these tests are used to guide diagnosis and treatment decisions associated with neurodevelopmental conditions, including genetic variants associated with epilepsy.Physicians with Substance Use Disorder, Part II: Available Treatment and Recovery Options
https://practicalneurology.com/columns/practice-management/physicians-with-substance-use-disorder-part-ii-available-treatment-and-recovery-options/30091/Chris Bundy, MD, Executive Medical Director, Washington Physicians Health Program, provides an overview of treatment and recovery options available to physicians with substance use disorder, including peer-to-peer support, medication, and Physician Health Programs.Safety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
https://practicalneurology.com/programs/practical-neurology/safety-monitoring-of-disease-modifying-therapies-in-multiple-sclerosis/31262/Aisha Elfasi, MD, Clinical and Research Fellow, Department of Neurology, Johns Hopkins University, provides an overview of the currently available disease-modifying therapies for multiple sclerosis, highlighting important safety considerations and routine monitoring requirements.SMA Experience: Episode 1
https://practicalneurology.com/diseases-diagnoses/neuromuscular/sma-experiences/30080/Neuromuscular disease expert Charlotte Sumner, MD chats with her patient Nicole Moore about some of her life goals and how recent treatment options have changed the conversations between them.Ocrevus Treatment in Pregnant and Lactating Women with Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ocrevus-treatment-pregnant-lactating-women-with-multiple-sclerosis/35558/Riley Bove, MD, UCSF School of Medicine, San Francisco, CA details results from the MINORE and SOPRANINO studies examining Ocrevus treatment in pregnant and lactating women with multiple sclerosis.Narcolepsy, Idiopathic Hypersomnia, and General Sleep Disorders
https://practicalneurology.com/programs/practical-neurology/narcolepsy-idiopathic-hypersomnia-and-general-sleep-disorders/30083/In this episode, Rajkumar Dasgupta, MD, Clinical Associate Professor at Keck School of Medicine of USC and sleep specialist, provides an in-depth review of what's new in sleep disorders, with a special focus on updates in narcolepsy and idiopathic hypersomnia.Factors Influencing the Selection of CSF Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-csf-tests-for-alzheimer-disease/35726/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of cerebrospinal fluid tests for Alzheimer disease.About the Cover Artist
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/audrius-v-plioplys-md-is-a-neurologist-who-has-merged-the-research-lab-with-the-art-studio/31667/Audrius V. Plioplys, MD, is a neurologist who has merged the research lab with the art studio.